Gynecologists are afraid of prescribing hormone replacement to endometrial/ovarian cancer survivors despite national guidelines—a survey in Sweden

Background: Prolonged survival in ovarian and endometrial cancer patients increases the importance of paying attention to quality of life. Hormone replacement therapy (HRT) after gynecologic cancer has been controversial. With this survey, we sought to describe Swedish gynecologists’ and gynecologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Halldorsdottir, Sandra, Dahlstrand, Hanna, Stålberg, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327604/
https://www.ncbi.nlm.nih.gov/pubmed/30526173
http://dx.doi.org/10.1080/03009734.2018.1544597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327604/
https://www.ncbi.nlm.nih.gov/pubmed/30526173
http://dx.doi.org/10.1080/03009734.2018.1544597

Ejemplares similares